Shaanxi Panlong Pharmaceutical Co., Ltd. logo

Shaanxi Panlong Pharmaceutical Co., Ltd. (002864)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
21. 94
-0.12
-0.544%
¥
3.7B Market Cap
20.21 P/E Ratio
0.4% Div Yield
3.2M Volume
0 Eps
¥ 22.06
Previous Close
Add Transaction
Day Range
21.88 22.26
Year Range
19 32.98
Want to track 002864 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002864 closed today lower at ¥21.94, a decrease of -0.544% from yesterday's close, completing a monthly increase of 10.9805% or ¥2.17. Over the past 12 months, 002864 stock lost -29.1344%.
002864 pays dividends to its shareholders, with the most recent payment made on Jul 22, 2026. The next estimated payment will be in In 11 months on Jul 22, 2027 for a total of ¥0.325.
The last earnings report, released on May 21, 2025, exceeded the consensus estimates by 0.2982%. On average, the company has surpassed earnings expectations by 0.2972%, based on the last three reports.
Shaanxi Panlong Pharmaceutical Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jul 22, 2026.
The company's stock is traded on one exchange.

002864 Chart

People also search for

Dr Corp Ltd.
¥ 23.35
-2.4237%
Sunvim Group Co., Ltd.
¥ 11.72
-3.3003%
Tibet Gaozheng Explosive Co., Ltd.
¥ 58.61
-1.6281%
Innovative Medical Management Co., Ltd.
¥ 21.24
-3.1022%
Henan Liliang Diamond Co., Ltd.
¥ 59.21
-1.366%

Shaanxi Panlong Pharmaceutical Co., Ltd. (002864) FAQ

What is the stock price today?

The current price is ¥21.94.

On which exchange is it traded?

Shaanxi Panlong Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002864.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.4%.

What is its market cap?

As of today, the market cap is 3.7B.

Has Shaanxi Panlong Pharmaceutical Co., Ltd. ever had a stock split?

Shaanxi Panlong Pharmaceutical Co., Ltd. had 1 splits and the recent split was on Jul 22, 2026.

Shaanxi Panlong Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Fengming Zhu CEO
XSHE Exchange
CNE1000032C9 ISIN
CN Country
933 Employees
22 Jul 2026 Last Dividend
22 Jul 2026 Last Split
- IPO Date

Overview

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd is a prominent entity in the Chinese pharmaceutical industry, dedicated to the research, development, production, and sale of Chinese patent medicines within China. Established in 1997 and headquartered in Xi'an, China, the company has carved a niche for itself by specializing in a wide range of therapeutic areas, catering to the health needs of various patient demographics.

Products and Services

The product portfolio of Shaanxi Panlong Pharmaceutical Group is extensive and diverse, targeting multiple therapeutic areas and health concerns. Here are some of the key categories along with an explanation for each:

  • Orthopedic: Specializing in treatments for bone and joint disorders, these products aim to alleviate symptoms related to orthopedic conditions.
  • Cardiovascular: Focused on heart health, these medicines help in the prevention and treatment of cardiovascular diseases.
  • Cerebrovascular: Designed to support brain health, these drugs are aimed at preventing and treating conditions affecting the brain's blood vessels.
  • Digestive: Catering to gastrointestinal health, these products address various digestive system disorders.
  • Respiratory: These medicines are intended for the treatment and management of respiratory tract diseases.
  • Pediatrics: Specifically formulated for children, these products cater to the healthcare needs of the pediatric population.
  • Gynecology: Targeted towards women's health, these medicines are designed for the treatment of gynecological disorders.
  • Hepatobiliary: Focusing on liver and gallbladder health, these drugs treat conditions affecting the hepatobiliary system.
  • Rheumatism and Bone Injury: Offering relief and treatment for rheumatic conditions and bone injuries, these products aim to improve musculoskeletal health.
  • Tonic: These supplements are designed to boost general wellbeing by providing essential nutrients and increasing vitality.
  • Heat-clearing and Detoxifying: Aimed at eliminating heat and toxins from the body, these products support overall health and immune system function.
  • Liver and Gallbladder Drugs: Specifically designed for liver and gallbladder disorders, these medicines help in enhancing the health and function of these organs.
  • Traditional Chinese Medicine Anti-inflammatory Products: Utilizing the principles of traditional Chinese medicine, these products offer natural anti-inflammatory benefits.

Contact Information

Address: No. 2801, Baliu 2nd Road, Xi'an, China, 710025
Phone: 86 29 8333 8888